SCHEDULE 13G: Champlain Investment Partners Discloses 5.0% Passive Stake in Phreesia, Inc.
Beneficial Ownership Report
Champlain Investment Partners, LLC has reported a passive beneficial ownership of 5.0% in Phreesia, Inc.'s common stock, totaling 2,946,489 shares, as of March 31, 2025.
Summary
- Champlain Investment Partners, LLC has filed a Schedule 13G, indicating beneficial ownership of Phreesia, Inc. common stock.
- The firm beneficially owns an aggregate of 2,946,489 shares, representing 5.0% of the class.
- Champlain Investment Partners, LLC holds sole voting power over 1,963,964 shares and sole dispositive power over all 2,946,489 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Phreesia, Inc.
Sentiment
Score: 6
Explanation: The filing of a passive 13G is generally neutral, but the disclosure of a new 5% stake by an institutional investor can be seen as a slight positive, indicating institutional interest and confidence in the company.
Positives
- The disclosure of a 5.0% stake by an investment adviser like Champlain Investment Partners, LLC can signal institutional confidence in Phreesia, Inc.
- The passive nature of the stake indicates that the investor is not seeking to influence management or control, which can be viewed positively by current management and other shareholders.
Negatives
- No specific negatives are indicated by this passive ownership filing.
Risks
- The document itself does not detail company-specific risks, but rather the nature of the reporting person's passive investment.
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Phreesia, Inc.'s future outlook.
Industry Context
This filing is a standard disclosure of beneficial ownership by an investment firm and does not provide specific insights into broader industry trends or competitive landscape for Phreesia, Inc. However, it indicates continued institutional interest in the healthcare technology sector, where Phreesia operates.
Stakeholder Impact
- Shareholders: The disclosure of a new institutional investor holding a significant stake may instill confidence and potentially attract further institutional investment.
- Management: The passive nature of the stake suggests no immediate threat to control or strategic direction from this investor.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (beneficial ownership threshold crossed or reporting period end). |
| 05/14/2025 | Date of filing/signature of the Schedule 13G. |
Keywords
Phreesia Inc, Champlain Investment Partners, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, Passive Investment, SEC Filing, Healthcare Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.